Skip to main content
. 2024 Nov 24;13(23):7095. doi: 10.3390/jcm13237095

Table 1.

Clinical characteristics of the study population.

Characteristics Male
(n = 15,838)
Female (n = 3116) Total Missing Value (%) p Value
Age at ULT initiation 51.2 ± 14.6 60.4 ± 14.9 0.0 <0.0001 ***
BMI 25.4 ± 3.3 24.8 ± 3.8 26.3 <0.0001 ***
Smoking 26.5 <0.0001 ***
None or past smoker 7371 (62.1) 1971 (95.1)
Current smoker 4492 (37.9) 102 (4.9)
Alcohol consumption 26.7 <0.0001 ***
None or occasional drinkers 8476 (71.6) 1974 (95.5)
Moderate drinker (≥3/week) 3358 (28.4) 93 (4.5)
Comorbidities (%) 0.0
Hypertension 10,186 (64.3) 2434 (78.1) <0.0001 ***
Diabetes mellitus 8751 (55.3) 2243 (72.0) <0.0001 ***
Chronic kidney disease 2998 (18.9) 1023 (32.8) <0.0001 ***
Cerebrovascular disease 3865 (24.4) 1297 (41.6) <0.0001 ***
Ischemic heart disease 5910 (37.3) 1686 (54.1) <0.0001 ***
Malignancy 3218 (20.3) 854 (27.4) <0.0001 ***
Systolic BP 128.9 ± 15.3 126.5 ± 16.8 26.3 <0.0001 ***
Diastolic BP 80.2 ± 10.4 77.3 ± 10.6 26.3 <0.0001 ***
Hemoglobin 14.7 ± 1.5 12.6 ± 1.4 26.3 <0.0001 ***
Creatinine 1.4 ± 1.8 1.2 ± 1.8 26.3 0.0031 **
Total cholesterol 197.0 ± 40.7 200.8 ± 42.3 26.3 0.0002 **
HDL 51.0 ± 26.6 56.1 ± 30.4 26.3 <0.0001 ***
LDL 114.2 ± 159.4 118.2 ± 51.4 27.4 0.0311 *
Triglyceride 192.8 ± 159.6 150.3 ± 131.8 26.3 <0.0001 ***
Death 2803 (17.7) 900 (28.9) 0.0 <0.0001 ***
Age at death 72.1 ± 12.3 75.4 ± 12.6 0.0 <0.0001 ***

Values are means ± standard deviations or numbers and frequencies (%). ULT, urate-lowering therapy, BMI, body mass index, BP, Blood pressure, HDL, high-density lipoprotein, LDL, low-density lipoprotein; *, p < 0.05; **, p < 0.01; ***, p < 0.001.